1. Home
  2. CJMB vs BIVI Comparison

CJMB vs BIVI Comparison

Compare CJMB & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CJMB
  • BIVI
  • Stock Information
  • Founded
  • CJMB 2007
  • BIVI 2013
  • Country
  • CJMB United States
  • BIVI United States
  • Employees
  • CJMB N/A
  • BIVI N/A
  • Industry
  • CJMB
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CJMB
  • BIVI Health Care
  • Exchange
  • CJMB NYSE
  • BIVI Nasdaq
  • Market Cap
  • CJMB 18.2M
  • BIVI 15.1M
  • IPO Year
  • CJMB 2025
  • BIVI N/A
  • Fundamental
  • Price
  • CJMB $5.04
  • BIVI $1.10
  • Analyst Decision
  • CJMB
  • BIVI Strong Buy
  • Analyst Count
  • CJMB 0
  • BIVI 1
  • Target Price
  • CJMB N/A
  • BIVI $30.00
  • AVG Volume (30 Days)
  • CJMB 29.5K
  • BIVI 821.9K
  • Earning Date
  • CJMB 01-01-0001
  • BIVI 05-12-2025
  • Dividend Yield
  • CJMB N/A
  • BIVI N/A
  • EPS Growth
  • CJMB N/A
  • BIVI N/A
  • EPS
  • CJMB N/A
  • BIVI N/A
  • Revenue
  • CJMB $6,563,412.00
  • BIVI N/A
  • Revenue This Year
  • CJMB N/A
  • BIVI N/A
  • Revenue Next Year
  • CJMB N/A
  • BIVI N/A
  • P/E Ratio
  • CJMB N/A
  • BIVI N/A
  • Revenue Growth
  • CJMB N/A
  • BIVI N/A
  • 52 Week Low
  • CJMB $3.38
  • BIVI $0.62
  • 52 Week High
  • CJMB $7.76
  • BIVI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • CJMB N/A
  • BIVI 54.63
  • Support Level
  • CJMB N/A
  • BIVI $1.05
  • Resistance Level
  • CJMB N/A
  • BIVI $1.29
  • Average True Range (ATR)
  • CJMB 0.00
  • BIVI 0.14
  • MACD
  • CJMB 0.00
  • BIVI 0.03
  • Stochastic Oscillator
  • CJMB 0.00
  • BIVI 56.18

About CJMB CALLAN JMB INC

Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology, and specialized cold chain logistics know-how. It provides a system that utilizes predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity and to provide immediate response in industries while ensuring environmental responsibility. The company views its solutions as disruptive to the older technologies of dry ice and liquid nitrogen in that its solutions are comprehensive and combine its competencies in configurations that are customized to its clients.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: